Melatonin inhibits oxidative modification of human low-density lipoprotein

Journal of Pineal Research

Volumn 22, Issue 4, 1997, Pages 203-209

  Kelly, Melissa R ^a   Loo, George ^a  

^a UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

Author keywords

Antioxidant; Low density lipoprotein; Melatonin

Indexed keywords

2,2' AZOBIS(2 AMIDINOPROPANE); 2,2'-AZOBIS(2-AMIDINOPROPANE); AMIDINE; ANTIOXIDANT; APOLIPOPROTEIN B; APOLIPOPROTEIN B100; COPPER; CUPRIC CHLORIDE; LOW DENSITY LIPOPROTEIN; MELATONIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

AGAR GEL ELECTROPHORESIS; ARTICLE; DOSE RESPONSE; DRUG EFFECT; HUMAN; METABOLISM; OXIDATION REDUCTION REACTION;

AMIDINES; ANTIOXIDANTS; APOLIPOPROTEIN B-100; APOLIPOPROTEINS B; COPPER; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, AGAR GEL; HUMANS; LIPOPROTEINS, LDL; MELATONIN; OXIDATION-REDUCTION; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0031133777     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-079X.1997.tb00323.x     Document Type: Article

References (32)

1. AVIRAM, M., G. DANKNER, U. GOGAN, E. HOCHGRAB, J.G. BROOK (1992) Lovastatin inhibits low-density lipoprotein oxidation and alters its fluidity and uptake by macrophages: In vitro and in vivo studies. Metabolism 41:229-235.
2. BARTLETT, G.R. (1959) Phosphorus assay in column chromatography. J. Biol. Chem. 234:266-468.
3. BLIGH, E.G., W.J. DYER (1959) A rapid method of total lipid extraction and purification. Canad. J. Biochem. Physiol. 37:911-917.
4. BREUGNOT, C., J.P. ILIOU, S. PRIVAT, F. ROBIN, J.P. VILAINE, A. LENAERS (1992) In vitro inhibition of the modification of low-density lipoprotein by indapamide. J. Cardiovasc. Pharmacol. 20:340-347.
5. DANIELS, W.M.U., R.J. REITER, D. MELCHIORRI, E. SEWERYNEK, M.I. PABLOS, G.G. ORTIZ (1995) Melatonin counteracts lipid peroxidation induced by carbon tetrachloride but does not restore glucose-6-phosphatase activity. J. Pineal Res. 19:1-6.
6. ESTERBAUER, H., G. STRIEGL, H. PUHL, M. ROTHENEDER (1989) Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radical Res. Commun. 6:67-75.
7. ESTERBAUER, H., J. GEBICKI, H. PUHL, G. JURGENS (1992) The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radical Biol. Med. 13:341-390.
8. FRANKEL, E.N., J. KANNER, J.B. GERMAN, E. PARKS, J.E. KINSELLA (1993) Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 341:454-457.
9. JIALAL, I., G.L. VEGA, S.M. GRUNDY (1990) Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein. Atherosclerosis 82:185-191.
10. JIALAL, I., E.P. NORKUS, L. CRISTOL, S.J. GRUNDY (1991) β-Carotene inhibits the oxidative modification of low density lipoprotein. Biochim. Biophys. Acta 1086:134-138.
11. KUZUYA, M., K. YAMADA, T. HAYASHI, C. FUNAKI, M. NAITO, K. ASAI, F. KUZUYA (1992) Role of lipoprotein-copper complex in copper catalyzed-peroxidation of low-density lipoprotein. Biochem. Biophys. Acta 1123:334-341.
12. 2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro. J. Clin. Invest. 93:998-1004.
13. MARKWELL, M.A.K., S.M. HAAS, L.L. BIEBER, N.E. TOLBERT (1978) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87:206-210.
14. MARSHAL, K.A., R. REITER, B. POEGGELER, O.I. ARUOMA, B. HALLIWELL (1996) Evaluation of the antioxidant activity of melatonin in vitro. Free Radical Biol. Med. 21:307-315.
15. MAZIERE, C., M. AUCLAIR, M.F. RONVEAUX, S. SALMON, R. SANTUS, J.C. MAZIERE (1991) Estrogens inhibit copper and cell-mediated modification of low density lipoprotein. Atherosclerosis 89:175-182.
16. MAZIERE, C., M. AUCLAIR, J.C. MAZIERE (1992) Lipophilic β-blockers inhibit monocyte endothelial cell-mediated modification of low density lipoproteins. Biochim. Biophys. Acta 1126:314-318.
17. 2+ mediated oxidation modification of low density lipoprotein. Biol. Pharm. Bull. 17:1567-1572.
18. PARKER, F., N.F. PETERSON (1965) Quantitative analysis of phospholipids and phospholipid fatty acids from silica gel thin-layer chromatograms. J. Lipid Res. 6:455-459.
19. 2 activity of apoprotein B-100. Proc. Natl. Acad. Sci. USA 87:9741-9745.
20. PARTHASARATHY, S., S.G. YOUNG, J.L. WITZUM, R.C. PITTMAN, D. STEINBERG (1986) Probucol inhibits oxidative modification of low density lipoprotein. J. Clin. Invest. 77:641-644.
21. PIERI, C., M. MAURIZIO, F. MORONI, R. RECCHIONI, F. MARCHESELLI (1994) Melatonin: A peroxyl radical scavenger more effective than vitamin E. Life Sci. 55:271-276.
22. PIERI, C., M. MARRA, R. GASPAR, S. DAMJANOVICH (1996) Melatonin protects LDL from oxidation but does not prevent the apolipoprotein derivatization. Biochem. Biophys. Res. Commun. 222:256-260.
23. PUHL, H., G. WAEG, H. ESTERBAUER (1994) Methods to determine oxidation of low-density lipoproteins. Meth. Enzymol. 233:425-441.
24. REITER, R.J., D. MELCHIORRI, E. SEWERYNEK, B. POEGGELER, L. BARLOW-WALDEN, J. CHUANG, G.G. ORTIZ, D. ACUNA-CASTROVIEJO (1995) A review of the evidence supporting melatonin's role as an antioxidant. J. Pineal Res. 18:1-11.
25. RIFICI, V.A., A.K. KHACHADURIAN (1992) The inhibition of low-density lipoprotein by 17-β estradiol. Metabolism 41:1110-1114.
26. SCAIANO, J.C. (1995) Exploratory laser flash photolysis study of free radical reactions and magnetic field effects in melatonin chemistry. J. Pineal Res. 19:189-195.
27. 2-induced lipid peroxidation in homogenates of different rat brain regions. J. Pineal Res. 19:51-56.
28. SMEJKAL, G.B., H.F. HOFF (1994) Cholesterol-specific probe for lipoprotein immobilized on nitrocellulose membranes. Biotechnology 16:68-70.
29. 2 mimics cell-mediated oxdiative modification. J. Lipid Res. 29:745-753.
30. STEINBERG, D., S. PARTHASARATHY, T.E. CAREW, J.C. KHOO, J.L. WITZTUM (1989) Beyond cholesterol: Modifications of low-density lipoprotein that increases its atherogenecity. New Eng. J. Med. 320:915-924.
31. TAN, D.X., L.D. CHEN, B. POEGGELER, L.C. MANCHESTER, R.J. REITER (1993) Melatonin: A potent, endogenous hydroxyl radical scavenger. Endocr. J. 1:57-60.
32. YUE, T.L., P.J. MCKENNA, P.G. LYSKO, R.R. RUFFOLO, JR., G.Z. FEUERSTEIN (1992) Carvedilol, a new antihypertensive, prevents oxidation of human low density lipoprotein by macrophages and copper. Atherosclerosis 97:209-216.